Skip to content

Cash ratio at other companies

Insulet logo
InsuletPODD
0.7×-1.8×
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
0.7×+0.5×
Medtronic logo
MedtronicMDT
0.2×0.0×
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
+0.7×
Mannkind logo
MannkindMNKD
0.4×0.0×
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
1.3×-1.3×

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Calculated from Embecta Corp.’s reported figures.

Based on the most recent quarter.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s cash ratio?
Embecta Corp. (EMBC) reported cash ratio of 0.8× in Q1 2026.
How has Embecta Corp.'s cash ratio changed year-over-year?
Embecta Corp.'s cash ratio decreased by 4.5% year-over-year, from 0.8× to 0.8×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.